Venture Capital

Tucuvi: $20 Million Series A Raised To Scale AI Care Management Platform

By Amit Chowdhry ● Jan 10, 2026

Tucuvi has raised $20 million in Series A funding to accelerate adoption of its AI Care Management platform across healthcare organizations, as systems grapple with workforce shortages, rising demand, and increasing operational complexity. The round was co-led by Cathay Innovation and Kfund through its early-growth fund Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling.

bit.bio Raises $50 Million Series C Led by M&G To Scale Human Cell Programming Platform

By Amit Chowdhry ● Jan 10, 2026

M&G Investments has led a $50 million Series C funding round for bit.bio, a Cambridge-based biotechnology company developing human cell programming technology to improve the speed and predictability of drug discovery and safety testing.

OpenAI And SoftBank Invest $1 Billion In SB Energy As Stargate Data Center Buildout Accelerates

By Amit Chowdhry ● Jan 10, 2026

SoftBank Group and OpenAI are investing a combined $1 billion in SB Energy to expand the company’s role as a development and execution partner for large-scale U.S. data center campuses and related energy infrastructure, the companies said Friday.

Kinaset Therapeutics: $103 Million Series B Closed To Advance Inhaled Pan-JAK Drug For Severe Asthma

By Amit Chowdhry ● Jan 10, 2026

Kinaset Therapeutics, a clinical-stage biopharmaceutical company focused on developing inhaled therapies for severe respiratory diseases, announced it has closed a $103 million oversubscribed Series B financing to fund mid-stage development of frevecitinib, its lead inhaled anti-inflammatory candidate for severe asthma and other serious respiratory diseases. The round was led by new investors RA Capital Management and Forge Life Science Partners, with participation from EQT Life Sciences, Vivo Capital, Schroders Capital, Willett Advisors, Pictet Alternative Advisors, and Sixty Degree Capital, alongside existing backers Atlas Venture, 5AM Ventures, and Gimv.

Rain: $250 Million Series C At $1.95 Billion Valuation Raised To Expand Stablecoin Payments Platform

By Amit Chowdhry ● Jan 10, 2026

Rain, which provides enterprise infrastructure for stablecoin-powered payments, has raised a $250 million Series C round led by ICONIQ, valuing the company at $1.95 billion. The financing brings Rain’s total funding to more than $338 million, and follows its Series B by about four months and its Series A by about 10 months.

Spruce Biosciences: Up To $50 Million Venture Debt Facility Secured To Support TA-ERT Path To Market

By Amit Chowdhry ● Jan 10, 2026

Spruce Biosciences announced it has entered into a venture debt loan facility for up to $50 million with Avenue Venture Opportunities Fund II, a fund of Avenue Capital Group, providing growth capital as the company advances tralesinidase alfa enzyme replacement therapy (TA-ERT) toward a planned biologics license application for Sanfilippo Syndrome Type B (MPS IIIB).

Veritas Capital To Buy Majority Stake In GHX

By Amit Chowdhry ● Jan 10, 2026

Veritas Capital announced it has entered into a definitive agreement, through an affiliate, to acquire a majority stake in Global Healthcare Exchange, a supply chain software platform that connects healthcare providers and suppliers. Existing shareholders Temasek and Warburg Pincus will remain invested alongside Veritas and support the company’s growth strategy. Financial terms were not disclosed.

Benefit Street Partners Closes Real Estate Opportunistic Debt Fund II At $10 Billion

By Amit Chowdhry ● Jan 10, 2026

Benefit Street Partners (BSP), a credit-focused alternative asset manager, announced it has reached a final close for BSP Real Estate Opportunistic Debt Fund II (ODF II), providing $10 billion of investable capital inclusive of related vehicles and anticipated leverage, backed by $3 billion of equity commitments. BSP said the raise is the largest in its history for its U.S. real estate debt strategy.

Presto Adds $10 Million To Advance Voice AI Rollout for Enterprise QSR Drive-Thrus

By Amit Chowdhry ● Jan 10, 2026

Presto announced it has added $10 million in new funding to accelerate its AI roadmap and expand deployments of its enterprise voice assistant for quick-service restaurant drive-thrus. The company positioned the raise as growth capital to scale production implementations and deepen its lead in voice AI for large QSR brands.

PureSpectrum Partners With TA Associates To Fund Product Innovation

By Amit Chowdhry ● Jan 10, 2026

PureSpectrum, a market research technology company, said it has entered into a strategic partnership with TA Associates to support continued innovation, platform scaling, and expanded value for customers across the market research ecosystem. Financial terms were not disclosed.

Carna Health: $8 Million Raised To Expand Global Chronic Kidney Disease Screening Platform

By Amit Chowdhry ● Jan 10, 2026

Carna Health announced it has raised $8 million to expand global access to its chronic kidney disease screening and care management technology, following a strategic partnership with Siemens Healthineers to scale preventive kidney care worldwide.

UPenn, BioNTech, And Osage University Partners Launch $50 Million Seed Fund To Back Penn Life Science Startups

By Amit Chowdhry ● Jan 10, 2026

The University of Pennsylvania, BioNTech SE, and Osage University Partners (OUP) announced the launch of the $50 million Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund), a dedicated venture fund focused on early-stage life science companies originating from Penn.

Hadrian Raises Funding At $1.6 Billion Valuation To Scale New U.S. Factories

By Amit Chowdhry ● Jan 10, 2026

Hadrian, a company focused on building advanced U.S. manufacturing capacity for aerospace, defense, and critical infrastructure, announced it has raised expanded capital led by accounts advised by T. Rowe Price Associates. The financing values the company at $1.6 billion, Hadrian said.

Guidepost Growth Equity Closes $521 Million Oversubscribed Fund IV

By Amit Chowdhry ● Jan 10, 2026

Guidepost Growth Equity announced it has closed its fourth fund, Guidepost Growth Equity IV, L.P., with $521 million in total commitments, exceeding the firm’s $500 million fundraising target. The growth equity firm said the vehicle was oversubscribed and drew commitments from both new and existing limited partners.

Vizgen: $48 Million Funding Raised To Scale Spatial Multi-Omics Platform

By Amit Chowdhry ● Jan 10, 2026

Vizgen, a spatial multi-omics company, announced it has closed a $48 million financing led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures, with participation from existing investors.

Enhanced Digital Group: Series A Funding Raised For Expanding Institutional Crypto Derivatives Offering

By Amit Chowdhry ● Jan 10, 2026

Enhanced Digital Group (EDG), a provider of digital asset derivatives solutions, said StoneX Digital, a division of StoneX Group Inc. (Nasdaq: SNEX), led its Series A financing round.

Abbelight: Series B Raised To Expand Super-Resolution Microscopy Adoption

By Amit Chowdhry ● Jan 10, 2026

Abbelight announced it has closed a Series B financing round led by AVANT BIO, as the Paris-based company looks to accelerate product innovation and broaden commercial adoption of its super-resolution microscopy solutions across a wider customer base.

EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline

By Amit Chowdhry ● Jan 10, 2026

EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and Johnson & Johnson, through Johnson & Johnson Innovation – JJDC, with participation from new and existing investors.

32 Biosciences: $40M Series A Launched To Advance GI Mucosal-Immune Therapeutics

By Amit Chowdhry ● Jan 10, 2026

32 Biosciences, a gastrointestinal-focused biotechnology company, announced it will launch a $40 million Series A financing during the 2026 J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026.

BrightHeart: €11 Million Series A Raised To Expand Prenatal Ultrasound AI Platform

By Amit Chowdhry ● Jan 10, 2026

BrightHeart, a Paris-based developer of AI software for prenatal ultrasound, said it has closed an €11 million Series A financing to fund U.S. commercialization, broader European expansion and continued product development for its B-Right AI Platform.

Spangle AI: $15 Million Series A Closed To Build Agentic Infrastructure For Commerce

By Amit Chowdhry ● Jan 10, 2026

Spangle AI, an agentic infrastructure layer for commerce, said it raised a $15 million Series A round led by NewRoad Capital Partners with participation from Madrona, DNX Ventures, Streamlined Ventures, and strategic angel investors, bringing total funding to $21 million.

Luxury Presence: $37 Million Raised To Advance Presence CRM, An AI Relationship Engine For Real Estate Agents

By Amit Chowdhry ● Jan 10, 2026

Luxury Presence, a growth platform used by more than 87,000 residential real estate agents and brands, announced it raised $37 million in new capital to accelerate the development and launch of Presence CRM, which it is positioning as an AI-driven system designed to surface deal opportunities from an agent’s existing network.

Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform

By Amit Chowdhry ● Jan 10, 2026

Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of synthesis. The round was co-led by Elaia, Pfizer Ventures, and Bpifrance as part of its InnoBio investment strategy, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest, and Mission BioCapital.

SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials

By Amit Chowdhry ● Jan 10, 2026

SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic medicine programs toward first-in-human studies.

Engitix: $25 Million Series A Extension Closed To Advance ECM-Targeted Pipeline In Oncology and Fibrosis

By Amit Chowdhry ● Jan 9, 2026

Engitix Therapeutics announced it has closed a $25 million Series A extension financing led by Netherton Investments, a fund investing on behalf of Mike Platt, co-founder and managing director of BlueCrest Capital Management.

Argobio Launches Enodia With €20.7 Million Seed Round To Develop Small Molecules For Protein Degradation

By Amit Chowdhry ● Jan 9, 2026

Argobio Studio announced it has launched Enodia Therapeutics and completed a €20.7 million ($25 million) seed financing to advance a small-molecule platform for targeted protein degradation at the point of protein synthesis, enabled by proteomics and machine learning.

Truelink Capital To Invest In Prime Electric

By Amit Chowdhry ● Jan 9, 2026

Truelink Capital announced it has signed a definitive agreement to make a significant investment in Prime Electric, a Bellevue, Washington-based provider of electrical system repair, installation and maintenance services. Financial terms were not disclosed.

Verana Health: $52 Million Raised And Merger With COTA

By Amit Chowdhry ● Jan 9, 2026

Verana Health announced it has merged with COTA, combining real-world data (RWD) assets and AI-driven curation technology to expand the scale and clinical depth of its offerings for biopharma customers across oncology and other specialties.

Broadview Group Invests In Citadel EHS

By Amit Chowdhry ● Jan 9, 2026

Broadview Group, a St. Louis-based private investment firm, announced it has invested Citadel EHS, an environmental, health, safety, and sustainability (EHS&S) consulting provider.

Lights Out Sports Sells Controlling Stake To A.R.I., Names Zack Ellison Chairman And CEO

By Amit Chowdhry ● Jan 9, 2026

Lights Out Sports said Applied Real Intelligence (A.R.I.) has acquired a controlling majority interest in the combat-sports and media platform, adding an expanded governance role as the company looks to scale across live events, streaming distribution, and brand partnerships.